Ph III, 28-wk, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess Efficacy, Safety, Tolerability of SC Omalizumab in Adults and Adolescents w/ Severe Persist. Allergic Asthma & Are Inadequately Controlled Despite GINA (2002) Step 4 Tx

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2001
The purpose of this study is to determine the effect of omalizumab, compared to placebo, on clinically significant asthma exacerbation rates in adolescents and adults with asthma.
Epistemonikos ID: 70cff5a91fc740249a62fc45eceb65ec85637cee
First added on: May 04, 2024